Cargando…
CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1
The CD5 transmembrane glycoprotein functions as a co-receptor in the signaling pathway linking T-cell antigen receptor (TCR) engagement to activation and differentiation. Although CD5 effects on TCR signaling have been shown to be primarily inhibitory, the underlying mechanisms remain unclear. In vi...
Autores principales: | DONG, BAOXIA, SOMANI, ALLY-KHAN, LOVE, PAUL E., ZHENG, XUAN, CHEN, XIEQUN, ZHANG, JINYI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899029/ https://www.ncbi.nlm.nih.gov/pubmed/27221212 http://dx.doi.org/10.3892/ijmm.2016.2592 |
Ejemplares similares
-
THEMIS enhances TCR signaling and enables positive selection by selective inhibition of SHP-1
por: Choi, Seeyoung, et al.
Publicado: (2017) -
CD5 Expression Is Developmentally Regulated By T Cell Receptor (TCR) Signals and TCR Avidity
por: Azzam, Hala S., et al.
Publicado: (1998) -
Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1
por: Watson, H Angharad, et al.
Publicado: (2016) -
Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
por: Presotto, Danilo, et al.
Publicado: (2017) -
Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)